Lance Baldo, Chief Medical Officer at Adaptive Biotechnologies Corp (ADPT), sold 4,167 shares at $40.00 ($167K) on 2020-09-11, disclosed to the SEC on 2020-09-11.
Open-market sale of $167k ADPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.00 | 18 | $720 | 0.4% |
| 2 | $40.00 | 4,149 | $166K | 99.6% |
| Total | $40.00 avg | 4,167 | $167K | 100% |
| Filing → |
| ADPT | SELL | 2021-04-16 | $89K | — | Filing → |
| ADPT | SELL | 2021-01-29 | $4.7M | — | Filing → |
| ADPT | SELL | 2020-12-09 | $442K | — | Filing → |